APA (7th ed.) Citation

YY, H., CY, T., CT, L., HC, F., CK, C., YC, Y., . . . HY, K. (2025). Targeting TNIP1 as a new therapeutic avenue for major depressive disorder. Brain, behavior, and immunity, 126, 214. https://doi.org/10.1016/j.bbi.2025.02.015

Chicago Style (17th ed.) Citation

YY, Hung, Tsai CY, Lee CT, Fu HC, Chou CK, Yang YC, Chen JF, and Kang HY. "Targeting TNIP1 as a New Therapeutic Avenue for Major Depressive Disorder." Brain, Behavior, and Immunity 126 (2025): 214. https://doi.org/10.1016/j.bbi.2025.02.015.

MLA (9th ed.) Citation

YY, Hung, et al. "Targeting TNIP1 as a New Therapeutic Avenue for Major Depressive Disorder." Brain, Behavior, and Immunity, vol. 126, 2025, p. 214, https://doi.org/10.1016/j.bbi.2025.02.015.